A Prospective, Randomized, Double-masked, Controlled Study on Intravitreal Bevacizumab (Avastin) Versus Verteporfin (Visudyne) Photodynamic Therapy (PDT) for Patients With Neovascular Age-related Macular Degeneration (AMD)
Latest Information Update: 05 Feb 2024
At a glance
- Drugs Bevacizumab (Primary) ; Verteporfin
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
Most Recent Events
- 05 Feb 2024 New trial record